Product Information
ACETAMINOPHEN 500 MG CAPLET is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0339 per EA under NDC 70010016110. Its NADAC has been published 73 times since May 14, 2025.
Strength
500 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010016110
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
2/15/2022
Price Statistics
The NADAC for ACETAMINOPHEN 500 MG CAPLET has been published 73 times since May 14, 2025, and over the history we have for it it has risen 4.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0339 per EA |
|---|---|
| All-time high | $0.0352 (Aug 12, 2026) |
| All-time low | $0.0306 (May 21, 2025) |
| 52-week high | $0.0352 |
| 52-week low | $0.0324 |
| Median price | $0.0334 |
| Average price | $0.0332 |
| Largest weekly change | -5.9% (May 21, 2025) |
| Weeks tracked | 73 |
| Tracking since | May 14, 2025 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Granules Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ACETAMINOPHEN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN 500 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN 500 MG CAPLET, manufactured by Granules Pharmaceuticals Inc., is $0.0339 per EA (NDC 70010016110), effective Sep 30, 2026.
How has the price of ACETAMINOPHEN 500 MG CAPLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN 500 MG CAPLET has risen 4.5%. It has been tracked across 73 weekly CMS publications since May 14, 2025.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN 500 MG CAPLET?
Since May 14, 2025, the NADAC for ACETAMINOPHEN 500 MG CAPLET has ranged from a low of $0.0306 (May 21, 2025) to a high of $0.0352 (Aug 12, 2026), with a median of $0.0334 per EA.
Are there cheaper alternatives to ACETAMINOPHEN 500 MG CAPLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACETAMINOPHEN 500 MG TABLET, is $0.0210 per EA — about 38% below ACETAMINOPHEN 500 MG CAPLET.
Who manufactures ACETAMINOPHEN 500 MG CAPLET?
ACETAMINOPHEN 500 MG CAPLET (NDC 70010016110) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.